- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07157293
- Original Trial
Online Intervention To Improve Motivation (Online Mot)
March 28, 2026 updated by: Lauren Luther, University of Alabama at Birmingham
An Online Intervention To Enhance Motivation and Goal-Directed Behavior
Participants will complete one online intervention lasting 12 weeks.
Each week, they will be asked to complete a 20-30 minute session online.
The intervention is targeting improved mood and positive affect in order to support increases in motivation and goal-directed behavior.
Before and after the intervention, participants will be asked to complete measures to assess symptoms, mood, and behavior.
Study Overview
Status
Not yet recruiting
Intervention / Treatment
Study Type
Interventional
Enrollment (Estimated)
60
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Lauren Luther
- Phone Number: 205-530-1117
- Email: cas-treatlab@uab.edu
Study Locations
-
-
Alabama
-
Birmingham, Alabama, United States, 35223-1517
- University of Alabama at Birmingham
-
Contact:
- Lauren Luther
- Phone Number: 205-530-1117
- Email: cas-treatlab@uab.edu
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Diagnosis of schizophrenia or a related psychotic disorder
- Meeting criteria for being at clinical high risk for psychosis
Exclusion Criteria:
- Does not have access to a computer each week
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Non-Randomized
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Online Motivation Focused Intervention
|
This is a online intervention that will ask participants to review and complete 30 minutes of material each week.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Brief Negative Symptom Scale
Time Frame: immediately before and after the intervention
|
Interview measure of motivation and pleasure
|
immediately before and after the intervention
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Estimated)
June 1, 2026
Primary Completion (Estimated)
May 1, 2028
Study Completion (Estimated)
August 1, 2028
Study Registration Dates
First Submitted
August 25, 2025
First Submitted That Met QC Criteria
August 28, 2025
First Posted (Actual)
September 5, 2025
Study Record Updates
Last Update Posted (Actual)
March 31, 2026
Last Update Submitted That Met QC Criteria
March 28, 2026
Last Verified
December 1, 2025
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 300015163
- Internal award (Other Identifier: UConn)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Psychosis
-
Columbia UniversityNational Institute of Mental Health (NIMH); University of California, Davis; University... and other collaboratorsRecruitingClinical High Risk | First Episode Psychosis | Early PsychosisUnited States
-
University of OxfordWellcome Trust; Jazz PharmaceuticalsNot yet recruitingClinical High Risk for Psychosis | Clinical High Risk for Psychosis (CHR) | Clinical High Risk for Developing PsychosisUnited Kingdom, Italy, Greece, Finland, Germany, Netherlands, Austria, Canada, Spain, Switzerland
-
Icahn School of Medicine at Mount SinaiNational Institute of Mental Health (NIMH)Enrolling by invitationFirst Episode Psychosis (FEP) | Clinical High Risk for Psychosis (CHR)United States
-
University of New MexicoNational Institute of Mental Health (NIMH)CompletedPsychosis | Clinical High Risk for Psychosis | First Episode PsychosisUnited States
-
Columbia UniversityNational Institute of Mental Health (NIMH)RecruitingClinical High Risk | First Episode Psychosis | Early PsychosisUnited States
-
Elazığ Mental Health and Diseases HospitalRecruitingMethamphetamine Induced PsychosisTurkey (Türkiye)
-
Shanghai Jiao Tong University School of MedicineGuangzhou Psychiatric Hospital; Suzhou Psychiatric Hospital; Tianjin Anding Hospital and other collaboratorsRecruitingSchizophrenia; Psychosis | Clinical High Risk | First Episode PsychosisChina
-
Stephanie MehlGerman Research Foundation; Charite University, Berlin, Germany; Ludwig-Maximilians... and other collaboratorsRecruitingPsychosis | Psychosis NOS | First-episode Psychosis | Schizophrenia Spectrum Disorders (SSD) | Randomized Controlled Trial (RCT) | Early Onset Psychosis | First Psychotic Episode Within the Last 5 YearsGermany
-
University of OxfordHospital General Universitario Gregorio Marañon; Charite University, Berlin... and other collaboratorsNot yet recruitingPsychosis | Treatment Resistant PsychosisSpain, United Kingdom, Germany, Israel, Greece, Italy, Netherlands, Switzerland
-
Chulalongkorn UniversityNational Research Council of Thailand; Thanyarak InstituteCompletedMethamphetamine-induced PsychosisThailand
Clinical Trials on Online Motivation Enhancing Intervention
-
University of AarhusAarhus University Hospital; Innovation Fund DenmarkCompletedGrass Pollen Allergy | RhinoconjunctivitisDenmark
-
Zurich University of Applied SciencesSwiss National Science FoundationCompleted
-
Hospital Clinic of BarcelonaInstituto de Salud Carlos III; Institut d'Investigacions Biomèdiques August... and other collaboratorsRecruitingBipolar and Related DisordersSpain
-
Uppsala UniversityNot yet recruitingIntimate Partner Violence | Resilience, PsychologicalSweden
-
Hasselt UniversityCompletedSedentary LifestyleBelgium
-
Danube University KremsNÖ Forschungs- und Bildungsges.m.b.H (NFB)CompletedIschemic Stroke | Dementia | Cognitive DeclineAustria
-
Rush University Medical CenterStanford UniversityCompleted
-
Hospices Civils de LyonRecruiting
-
Universidad Nacional Autonoma de MexicoNot yet recruitingDepression | Anxiety Disorders | Emotional Disorder | Stress Related DisorderMexico
-
The Miriam HospitalNational Heart, Lung, and Blood Institute (NHLBI)Active, not recruiting